CHROMADERM

Chromaderm develops a topical inhibitor of melanin production as a first-in-class therapy for skin brightening, melasma, and other skin diseases associated with increased melanin production.

#SimilarOrganizations #More

CHROMADERM

Industry:
Biotechnology Medical Therapeutics

Status:
Active


Similar Organizations

ion-biotechnology-usa-inc-logo

Ion Biotechnology (USA), Inc.

Ion Biotechnology is developing drugs based on ionic metals which show promise against a range of cancers and infectious disease.

not_available_image

Sunol Molecular

A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.

tilden-bio-logo

Tilden Bio

Tilden Bio develops photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins.

More informations about "Chromaderm" on Search Engine